Ranbaxy Labs' consolidated revenues felll 18 percent on yearly basis to Rs 2,683 crore during April-June quarter, which was higher-than-expectations of Rs 2,590 crore.
first published: Aug 7, 2013 05:21 pm
A collection of the most-viewed Moneycontrol videos.
Live: Sensex, Nifty extend surge to third day led by banking, IT stocks | Closing Bell
Tata Capital's Mega Rs 15,500 Cr IPO Kicks Off| Management On Future Outlook| IPO Watch Live
Live: Big IPOs, Q2 earnings season: Markets enter action-packed week | Opening Bell
The 23-Year-Old Struggling It Out As A Real Estate Broker | The Tenant
